<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>niacin</title><link>http://www.unboundmedicine.com/medline/ebm/research/niacin</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Chapter 30 Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19892133/full_citation/Chapter_30_Historical_aspects_of_the_major_neurological_vitamin_deficiency_disorders:_the_water_soluble_B_vitamins_</link><description>Lanska DJ <br/><span class="title">Chapter 30 Historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins. [Journal Article]</span><br/><span class="source" title="Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn">Handb Clin Neurol 2009.:445-76.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19892133/abstract/Chapter_30_Historical_aspects_of_the_major_neurological_vitamin_deficiency_disorders:_the_water_soluble_B_vitamins_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19892133/full_citation/Chapter_30_Historical_aspects_of_the_major_neurological_vitamin_deficiency_disorders:_the_water_soluble_B_vitamins_">Full Citation</a></description></item><item><title>Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19891279/full_citation/Targeting_low_HDL_cholesterol_to_decrease_residual_cardiovascular_risk_in_the_managed_care_setting_</link><description>Cziraky MJ, Watson KE, Talbert RL <br/><span class="title">Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of managed care pharmacy : JMCP">J Manag Care Pharm 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19891279/abstract/Targeting_low_HDL_cholesterol_to_decrease_residual_cardiovascular_risk_in_the_managed_care_setting_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19891279/full_citation/Targeting_low_HDL_cholesterol_to_decrease_residual_cardiovascular_risk_in_the_managed_care_setting_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19891279/Targeting_low_HDL_cholesterol_to_decrease_residual_cardiovascular_risk_in_the_managed_care_setting_">Find Related Articles</a> </description></item><item><title>Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19084089/full_citation/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_</link><description>Jones PH <br/><span class="title">Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering. [Journal Article]</span><br/><span class="source" title="The American journal of cardiology">Am J Cardiol 2008 Dec 22; 102(12A):41L-47L.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19084089/abstract/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19084089/full_citation/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19084089/Expert_perspective:_reducing_cardiovascular_risk_in_metabolic_syndrome_and_type_2_diabetes_mellitus_beyond_low_density_lipoprotein_cholesterol_lowering_">Find Related Articles</a> </description></item><item><title>A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19084086/full_citation/A_review_of_the_current_status_of_the_management_of_mixed_dyslipidemia_associated_with_diabetes_mellitus_and_metabolic_syndrome_</link><description>Davidson M <br/><span class="title">A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome. [Journal Article]</span><br/><span class="source" title="The American journal of cardiology">Am J Cardiol 2008 Dec 22; 102(12A):19L-27L.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19084086/abstract/A_review_of_the_current_status_of_the_management_of_mixed_dyslipidemia_associated_with_diabetes_mellitus_and_metabolic_syndrome_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19084086/full_citation/A_review_of_the_current_status_of_the_management_of_mixed_dyslipidemia_associated_with_diabetes_mellitus_and_metabolic_syndrome_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19084086/A_review_of_the_current_status_of_the_management_of_mixed_dyslipidemia_associated_with_diabetes_mellitus_and_metabolic_syndrome_">Find Related Articles</a> </description></item><item><title>Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19884623/full_citation/Systematic_review:_comparative_effectiveness_and_harms_of_combination_therapy_and_monotherapy_for_dyslipidemia_</link><description>Sharma M, Ansari MT, Abou-Setta AM, et al. <br/><span class="title">Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia. [Journal Article, Research Support, U.S. Gov't, P.H.S.]</span><br/><span class="source" title="Annals of internal medicine">Ann Intern Med 2009 Nov 3; 151(9):622-30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19884623/abstract/Systematic_review:_comparative_effectiveness_and_harms_of_combination_therapy_and_monotherapy_for_dyslipidemia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19884623/full_citation/Systematic_review:_comparative_effectiveness_and_harms_of_combination_therapy_and_monotherapy_for_dyslipidemia_">Full Citation</a> | <a href="http://www.annals.org/cgi/pmidlookup%3fview=long%26amp;pmid=19884623">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19884623/Systematic_review:_comparative_effectiveness_and_harms_of_combination_therapy_and_monotherapy_for_dyslipidemia_">Find Related Articles</a> </description></item><item><title>Niacin Improves Renal Lipid Metabolism and Slows Progression in Chronic Kidney Disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878707/full_citation/Niacin_Improves_Renal_Lipid_Metabolism_and_Slows_Progression_in_Chronic_Kidney_Disease_</link><description>Cho KH, Kim HJ, Kamanna VS, et al. <br/><span class="title">Niacin Improves Renal Lipid Metabolism and Slows Progression in Chronic Kidney Disease. [JOURNAL ARTICLE]</span><br/><span class="source" title="Biochimica et biophysica acta">Biochim Biophys Acta 2009 Oct 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878707/abstract/Niacin_Improves_Renal_Lipid_Metabolism_and_Slows_Progression_in_Chronic_Kidney_Disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878707/full_citation/Niacin_Improves_Renal_Lipid_Metabolism_and_Slows_Progression_in_Chronic_Kidney_Disease_">Full Citation</a></description></item><item><title>Mechanisms of flushing due to niacin and abolition of these effects.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19878384/full_citation/Mechanisms_of_flushing_due_to_niacin_and_abolition_of_these_effects_</link><description>Sood A, Arora R <br/><span class="title">Mechanisms of flushing due to niacin and abolition of these effects. [Journal Article]</span><br/><span class="source" title="Journal of clinical hypertension (Greenwich, Conn.)">J Clin Hypertens (Greenwich) 2009 Nov; 11(11):685-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19878384/abstract/Mechanisms_of_flushing_due_to_niacin_and_abolition_of_these_effects_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19878384/full_citation/Mechanisms_of_flushing_due_to_niacin_and_abolition_of_these_effects_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19878384/Mechanisms_of_flushing_due_to_niacin_and_abolition_of_these_effects_">Find Related Articles</a> </description></item><item><title>Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19874993/full_citation/Assessing_niacin_as_an_atherosclerosis_therapeutic_agent_valuable_insights_provided_by_high_resolution_vascular_magnetic_resonance_imaging_</link><description>Jaffer FA <br/><span class="title">Assessing niacin as an atherosclerosis therapeutic agent valuable insights provided by high-resolution vascular magnetic resonance imaging. [Editorial]</span><br/><span class="source" title="Journal of the American College of Cardiology">J Am Coll Cardiol 2009 Nov 3; 54(19):1795-6.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19874993/full_citation/Assessing_niacin_as_an_atherosclerosis_therapeutic_agent_valuable_insights_provided_by_high_resolution_vascular_magnetic_resonance_imaging_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0735-1097(09)02644-8">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19874993/Assessing_niacin_as_an_atherosclerosis_therapeutic_agent_valuable_insights_provided_by_high_resolution_vascular_magnetic_resonance_imaging_">Find Related Articles</a> </description></item><item><title>Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19864122/full_citation/Test_retest_stability_of_the_oral_niacin_test_and_electrodermal_activity_in_patients_with_schizophrenia_</link><description>Nilsson BM, Hultman CM, Ekselius L <br/><span class="title">Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia. [JOURNAL ARTICLE]</span><br/><span class="source" title="Prostaglandins, leukotrienes, and essential fatty acids">Prostaglandins Leukot Essent Fatty Acids 2009 Oct 26.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19864122/abstract/Test_retest_stability_of_the_oral_niacin_test_and_electrodermal_activity_in_patients_with_schizophrenia_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19864122/full_citation/Test_retest_stability_of_the_oral_niacin_test_and_electrodermal_activity_in_patients_with_schizophrenia_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19864122/Test_retest_stability_of_the_oral_niacin_test_and_electrodermal_activity_in_patients_with_schizophrenia_">Find Related Articles</a> </description></item><item><title>Do statins reduce hepatitis C RNA titers during routine clinical use?</title><link>http://www.unboundmedicine.com/medline/ebm/record/19859994/full_citation/Do_statins_reduce_hepatitis_C_RNA_titers_during_routine_clinical_use</link><description>Forde KA, Law C, O'Flynn R, et al. <br/><span class="title">Do statins reduce hepatitis C RNA titers during routine clinical use? [JOURNAL ARTICLE]</span><br/><span class="source" title="World journal of gastroenterology : WJG">World J Gastroenterol 2009 Oct 28; 15(40):5020-5027.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19859994/abstract/Do_statins_reduce_hepatitis_C_RNA_titers_during_routine_clinical_use">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19859994/full_citation/Do_statins_reduce_hepatitis_C_RNA_titers_during_routine_clinical_use">Full Citation</a></description></item></channel></rss>